ADVANCED OR METASTATIC SOLID MALIGNANCIES

Clinical trials for ADVANCED OR METASTATIC SOLID MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new ADVANCED OR METASTATIC SOLID MALIGNANCIES trials appear

Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Cancer patients get extended access to experimental drug after showing benefit

Disease control Completed

This study allowed patients with advanced cancers who were already benefiting from sitravatinib in a previous trial to continue receiving the drug. It monitored the safety and side effects of continued treatment with sitravatinib, either alone or combined with other cancer therap…

Matched conditions: ADVANCED OR METASTATIC SOLID MALIGNANCIES

Phase: PHASE2, PHASE3 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ADVANCED OR METASTATIC SOLID MALIGNANCIES

Get alerted when new ADVANCED OR METASTATIC SOLID MALIGNANCIES trials appear

Cancer patients get extended access to experimental drug after showing benefit